Clinical Trial Update: Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)

View source ↗

Summary

This completed trial assessed whether hydroxychloroquine affects AnxA5 resistance in antiphospholipid antibody–positive patients, with and without systemic lupu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Antibody Associated Thrombophilia
• Antiphospholipid Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Antiphospholipid Syndrome, Thrombophilia Due to Antiphospholipid Antibody | Status: COMPLETED